The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index; 27 of the 46 sources its claims cite were checked for support.
Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle?
Open accessPublished version of a preprint
Abstract
Fenofibrate (FEN) is an antilipidemic drug that increases the activity of the lipoprotein lipase enzyme, thus enhancing lipolysis; however, it may cause myopathy and rhabdomyolysis in humans. Coenzyme Q10 (CoQ10) is an endogenously synthesized compound that is found in most living cells and plays an important role in cellular metabolism. It acts as the electron carrier in the mitochondrial respiratory chain. This study aimed to elucidate FEN-induced skeletal muscle changes in rats and to evaluate CoQ10 efficacy in preventing or alleviating these changes. Forty adult male rats were divided equally into four groups: the negative control group that received saline, the positive control group that received CoQ10, the FEN-treated group that received FEN, and the FEN + CoQ10 group that received both FEN followed by CoQ10 daily for 4 weeks. Animals were sacrificed and blood samples were collected to assess creatine kinase (CK). Soleus muscle samples were taken and processed for light and electron microscopic studies. This study showed that FEN increased CK levels and induced inflammatory cellular infiltration and disorganization of muscular architecture with lost striations. FEN increased the percentage of degenerated collagen fibers and immune expression of caspase-3. Ultrastructurally, FEN caused degeneration of myofibrils with distorted cell organelles. Treatment with CoQ10 could markedly ameliorate these FEN-induced structural changes and mostly regain the normal architecture of muscle fibers due to its antifibrotic and antiapoptotic effects. In conclusion, treatment with CoQ10 improved muscular structure by suppressing oxidative stress, attenuating inflammation, and inhibiting apoptosis.
Overview
CoChat Summary
TL;DR
In adult male rats, fenofibrate caused skeletal muscle degeneration, fibrosis, apoptosis, and elevated creatine kinase, while coenzyme Q10 co-treatment markedly ameliorated these changes. CoQ10 improved structure and biochemistry but did not fully restore all parameters to control levels.
Key findings
- FEN increased serum creatine kinase to 1416.47 ± 210.62 versus 753.51 ± 72.06 in controls (p < 0.001); CoQ10 reduced it to 987.54 ± 125.73 (p < 0.001 vs FEN), though it remained higher than control (p = 0.011).
- FEN increased degenerated soleus muscle fibers to 21.66 ± 3.05%; CoQ10 reduced this to 7.74 ± 0.66% (p < 0.001 vs FEN), still above control (p = 0.008).
- FEN increased collagen fiber area to 21.75 ± 3.68% versus 4.42 ± 0.98% in controls (p < 0.001); CoQ10 reduced it to 9.14 ± 1.84% (p < 0.001 vs FEN), still above control (p = 0.042).
- FEN increased caspase-3-positive fiber area to 26.79 ± 4.62% versus 2.06 ± 0.29% in controls (p < 0.001); CoQ10 reduced it to 10.35 ± 2.37% (p < 0.001 vs FEN), still above control (p = 0.005). SDH staining was weak in FEN and moderate after CoQ10.
Methods
- Forty adult male rats (3–4 months old, 180–200 g) were randomized into four equal groups: negative control (saline), positive control (CoQ10 100 mg/kg/day), FEN (60 mg/kg/day), and FEN + CoQ10, all by gastric tube daily for 4 weeks.
- Soleus muscle was assessed by H&E, Mallory’s trichrome, SDH histochemistry, caspase-3 immunohistochemistry, and transmission electron microscopy; blood was assayed for creatine kinase.
- Morphometric measurements used ImageJ, and statistical analysis used SPSS with one-way ANOVA followed by Tukey post-hoc test; p ≤ 0.05 was significant.
Limitations
- The paper states there was no in-depth analysis of the mechanism of CoQ10’s protective effect and a lack of in-depth biochemical investigations such as tissue oxidative enzymes and troponin.
- Evident from the text: findings are limited to adult male albino rats over a 4-week treatment period, with no female animals, dose-response assessment, or human data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
22 Valid · 1 Not valid · 17 Not checked · 39 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“FEN has a selective effect on type I muscle fibers via upregulation of genes of beta-oxidation of fatty acid.”
§ Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? > Discussion
What the sources say
- Partly supportedcites Bodie et al. 2016 sourceExperimental — accuracy not yet measured
The Introduction (page not specified in our copy) reports that fenofibrate selectively affects type I muscle fibers and links this to increased fatty-acid uptake and beta-oxidation. It does not say that upregulation of beta-oxidation genes mediates that effect. The gene-expression results in §3.5 concern clofibrate, not fenofibrate, and describe dysregulated genes rather than that proposed mechanism. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Al-Megrin et al. (2020) stated that CoQ10 also prevents the migration of leukocytes, macrophages, and monocytes, which are mainly responsible for production of proinflammatory cytokines.”
§ Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? > Discussion
What the sources say
- Supportedcites Al-Megrin et al. 2020 source
The Discussion reports that CoQ10 reduces the migration of leukocytes and monocytes or macrophages responsible for producing pro-inflammatory cytokines. This supports the citing sentence’s substantive claim about CoQ10’s anti-migratory effect. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It is also found in the cell membrane and represents a principal molecule in the maintenance of the antioxidant system for protecting phospholipids of membranes from peroxidation, acting as a membrane stabilizer for the cell membrane and all intracellular membranes.”
§ Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? > Introduction
What the sources say
- Partly supportedcites Silva et al. 2022 sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says CoQ10 protects against lipid peroxidation and acts as a membrane stabilizer. It does not specify phospholipids or say that this protection extends to all intracellular membranes. (LLM, conf=0.83)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In addition, it can protect membrane proteins and deoxyribonucleic acid (DNA) against oxidative damage (Silva et al. 2022).”
§ Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? > Introduction
What the sources say
- Partly supportedcites Silva et al. 2022 sourceExperimental — accuracy not yet measured
The Introduction states that CoQ10 inhibits protein oxidation and DNA damage and acts as a membrane stabilizer. It does not specifically identify membrane proteins as the proteins protected, so the claim is more specific than the passage supports. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It was reported that induced activity of PPAR-α by FEN may lead to increased peroxisomal β-oxidation and consequent oxidative stress injury and damage of muscle tissue”
§ Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? > Discussion
What the sources say
- Partly supportedcites Phua et al. 2018 sourceExperimental — accuracy not yet measured
Section 1 identifies fenofibrate as a fibrate with predominant PPARα activity that induces lipid oxidation. Section 9 says increased oxidative stress and tissue damage may be associated with PPARα-induced activity, but describes the mechanism as unclear; it does not identify increased peroxisomal β-oxidation as the intervening mechanism. (LLM, conf=0.86)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
39 more claims · 3 with their cited sources checked
Create a free account to see all 79 claims and to verify the 3 references still open.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 20
- The quote only partly states this claim. 4
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? > Material and methods > Obtaining the samples
“Other small muscle specimens (1 mm) were put in a mixture of 2.5% glutaraldehyde and 2% paraformaldehyde, postfixed in 1% osmium tetroxide, and processed to obtain semi-thin sections (toluidine blue stained) and ultrathin sections for electron microscopy.”
§ Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? > Material and methods > Transmission electron microscopy (TEM)
“Subsequently, the specimens were postfixed for 1 h at 4 °C in 2% osmium tetroxide in 0.1 mol/l sodium cacodylate buffer (pH 7.4).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? > Results > Histochemically stained sections (SDH)
“In the control group, histochemical study of frozen TS of the soleus muscle for detection of SDH activity showed that this muscle consisted mainly of deeply stained fibers (type I) (Fig. 2e). Sections of the FEN group showed a weak reaction in most fibers (Fig. 2f), while those of the FEN + CoQ10 group showed a moderate increase in the intensity of the staining reaction compared with the FEN group (Fig. 2g).”
§ Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? > Results > Toluidine blue-stained sections
“(d) The control group shows high SDH staining intensity (crossed arrow). (e) The FEN group shows weak intensity (crossed arrow). (f) The FEN + CoQ10 group shows moderate intensity (crossed arrow).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? > Material and methods > Biochemical assessment
“Blood samples were collected from the tail vein of all animals to estimate the plasma level of creatine kinase (CK) as a biomarker for myopathy and muscle breakdown”
§ Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? > Results > Biochemical results
“#### Serum creatine kinase level”
Citations
Cites
Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges
Arenas‐Jal, M., Suñé‐Negre, J. M., & García‐Montoya, E. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12539 · Cited by 239
Bancroft, J. D., & Layton, C. (2019) · Bancroft's Theory and Practice of Histological Techniques · doi:10.1016/b978-0-7020-6864-5.00010-4 · Cited by 191
Garrido‐Maraver, J., Cordero, M. D., Oropesa-Ávila, M., Fernández-Vega, A., de la Mata, M., Pavón, A. D., de Miguel, M., Calero, C. P., Paz, M. V., Cotán, D., et al. (2014) · Molecular Syndromology · doi:10.1159/000360101 · Cited by 181
Clinical applications of coenzyme Q₁₀
Garrido-Maraver, J. (2014) · Frontiers in Bioscience · doi:10.2741/4231 · Cited by 178
Coenzyme Q10 deficiencies: pathways in yeast and humans
Awad, A. M., Bradley, M. C., Fernández-del-Río, L., Nag, A., Tsui, H. S., & Clarke, C. F. (2018) · Essays in Biochemistry · doi:10.1042/ebc20170106 · Cited by 137 · cited 1×
“Coenzyme Q10 (CoQ1) is a lipid-soluble compound that is naturally synthesized in smooth endoplasmic reticulum by the mevalonate pathway (Awad et al. 2018).”
BackgroundAntioxidant efficacy of vitamin D
Mokhtari, Z., Hekmatdoost, A., & Nourian, M. (2016) · Journal of Parathyroid Disease · Cited by 118
PPAR-Mediated Toxicology and Applied Pharmacology
Xi, Y., Zhang, Y., Zhu, S., Luo, Y., Xu, P., & Huang, Z. (2020) · Cells · doi:10.3390/cells9020352 · Cited by 115 · cited 1×
“Type I muscle fibers are more sensitive to this effect (Xi et al. 2020).”
BackgroundRole of Coenzyme Q10 in Health and Disease: An Update on the Last 10 Years (2010–2020)
Cirilli, I., Damiani, E., Dludla, P. V., Hargreaves, I., Marcheggiani, F., Millichap, L. E., Orlando, P., Silvestri, S., & Tiano, L. (2021) · Antioxidants · doi:10.3390/antiox10081325 · Cited by 115
S. Yousef, A. O., A. Fahad, A., Abdel Moneim, A. E., Metwally, D. M., El-khadragy, M. F., & Kassab, R. B. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16162895 · Cited by 110
Kim, N. H., Han, K. H., Choi, J., Lee, J., & Kim, S. G. (2019) · BMJ · doi:10.1136/bmj.l5125 · Cited by 107 · cited 1×
“Statins mainly lower cholesterol levels, while fibrates mainly lower fatty acids and triglycerides (TG) (Tarantino et al. 2017; Kim et al. 2019).”
Background
Research works printed but not linked: 1
- Chhetry M, Jialal I (2020) Lipid Lowering Drug Therapy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing https://www.ncbi.nlm.nih.gov/books/NBK541128/.
Cited by
Abdallah, G., Taha, M. M., & Hassanein, K. M. (2025) · Assiut veterinary medical journal · doi:10.21608/avmj.2025.380543.1684
“CoQ10 acts as a powerful antioxidant that scavenges free radicals, prevents the initiation and propagation of lipid peroxidation and acts as a membrane stabilizer for the cell membrane and all intracellular membranes (Crane, 2001 and El-Bassouny et al., 2023).”
Advances in the Regulation by Immune Cells of Skeletal Myositis Outcomes
Huang, S.-X., Zhao, Y., Xin, Y., et al. (2025) · Aging and Disease · doi:10.14336/ad.2025.0549
“Intracellular calcium dysregulation and coenzyme Q10 (CoQ10) depletion exacerbate oxidative stress (via nicotinamide adenine dinucleotide phosphate [NADPH] oxidase-driven ROS), worsening sarcolemmal damage [63,64].”
Metadata
- Authors
- El-Bassouny, D. R., Mansour, A. A., Ellakkany, A. S., Ayuob, N. N., & AbdElfattah, A. A.
- Affiliations
- Mansoura University (EG)
- Damietta University (EG)
- Corresponding author
- AbdElfattah, Amany A.
- Venue
- Histochemistry and Cell Biology
- Published
- 2023-06-04
- Volume
- 160
- Issue
- 2
- Pages
- 147-158
- ISSN
- 0948-6143 (ISSN-L)
- 1432-119X
- PMC
- PMC10386954
- OpenAlex
- W4379278545
- Cited by
- 0
- References
- 42
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Histochemistry and Cell Biology (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Mansoura University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- fenofibrate, coenzyme Q10, skeletal muscle toxicity, myopathy, rhabdomyolysis, creatine kinase, soleus muscle, myofibrillar degeneration, caspase-3, apoptosis, oxidative stress, muscle inflammation, antifibrotic effect, mitochondrial respiratory chain
- MeSH terms
- Adult, Animals, Humans, Male, Muscular Diseases, Fenofibrate, Ubiquinone, Muscle, Skeletal, Muscle Fibers, Skeletal, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? https://app.cochat.ai/papers/10.1007/s00418-023-02205-5
- The paper
- El-Bassouny, D. R., Mansour, A. A., Ellakkany, A. S., Ayuob, N. N., & AbdElfattah, A. A. (2023). Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? Histochemistry and Cell Biology. https://doi.org/10.1007/s00418-023-02205-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.